NEW YORK (GenomeWeb) – Sygnis today announced a non-exclusive deal with Biotop to distribute Sygnis' products in Scandinavia.
Sygnis has granted Finnish firm Biotop the non-exclusive rights to promote, market, and sell TruePrime and SunScript products. TruePrime products are for primer-free DNA amplification and are based on Sygnis' proprietary DNA primase TthPrimPol and Phi29 polymerase, which enables the amplification of total genomic DNA from amounts of samples down to single cells without the need for random synthetic primers, said Sygnis, which has offices in Germany and Spain.
SunScript reverse transcriptase kits are for translating RNA into DNA and are engineered for high thermostability.
Financial and other terms of the agreement were not disclosed. Last week, Sygnis and Welgene Biotech announced a distribution deal covering Taiwan for TruePrime and SunScript.
Biotop provides molecular biology research reagents as well as reagents for next-generation sequencing applications.